Disease Info Card

Arthritis, Juvenile Rheumatoid

Information about Arthritis, Juvenile Rheumatoid: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Arthritis, Juvenile Rheumatoid

Most recent studies have shown that Arthritis, Juvenile Rheumatoid shares some biological mechanisms with ankylosing-spondylitis, anterior-uveitis, arthritis, arthritis-psoriatic, arthropathy, autoimmune-diseases, autoimmune-reaction, chronic-arthritis, edema, exanthema, inflammation, juvenile-onset-still-disease, lupus-erythematosus-systemic, pain, polyarthritis, rheumatism, rheumatoid-arthritis, spondylitis, synovitis, uveitis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Arthritis, Juvenile Rheumatoid, and have been seen in publications frequently: Bone Mineralization, Bone Resorption, Cell Activation, Cell Proliferation, Chemotaxis, Coagulation, Complement Activation, Cytokine Production, Excretion, Glycosylation, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Macrophage Activation, Ossification, Pathogenesis, Response To Methotrexate, Secretion, Translation

Quite a number of genes have been found to play important roles in Arthritis, Juvenile Rheumatoid, such as ACR, C3, CRP, CSRP1, CTLA4, ESR1, HLA-DPB1, HLA-DQA1, HLA-DRB1, HLA-DRB4, HSPD1, IL10, IL1B, IL1RN, IL2, IL4, IL6, NOD2, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.